These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 9646266

  • 1. [Interrelationship between the duration of HIV infection, viral load and CD4 positive lymphocyte count].
    Soriano V, Gómez-Cano M, Castilla J, Villalba N, Holguín A, Bravo R, Mas A, Pérez-Labad ML, González-Lahoz J.
    Med Clin (Barc); 1998 Apr 25; 110(14):529-31. PubMed ID: 9646266
    [Abstract] [Full Text] [Related]

  • 2. [Value of HIV-1 viral load and CD4 lymphocyte count as determinants of progression to AIDS and survival].
    Romeu J, Balagué M, Ruiz L, Marfil S, Puig T, Arnó A, Veny A, Tural C, Sirera G, Clotet B.
    Med Clin (Barc); 1998 Jun 06; 110(20):761-7. PubMed ID: 9666416
    [Abstract] [Full Text] [Related]

  • 3. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
    Hoen B, Cooper DA, Lampe FC, Perrin L, Clumeck N, Phillips AN, Goh LE, Lindback S, Sereni D, Gazzard B, Montaner J, Stellbrink HJ, Lazzarin A, Ponscarme D, Staszewski S, Mathiesen L, Smith D, Finlayson R, Weber R, Wegmann L, Janossy G, Kinloch-de Loes S, QUEST Study Group.
    Clin Infect Dis; 2007 Aug 01; 45(3):381-90. PubMed ID: 17599319
    [Abstract] [Full Text] [Related]

  • 4. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Rickenbach M, Hirschel B, Battegay M, Swiss HIV Cohort Study.
    Clin Infect Dis; 2005 Aug 01; 41(3):361-72. PubMed ID: 16007534
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of HIV-1 phenotype in viral pathogenesis and its relation to viral load and CD4+ T-cell count.
    Kupfer B, Kaiser R, Rockstroh JK, Matz B, Schneweis KE.
    J Med Virol; 1998 Nov 01; 56(3):259-63. PubMed ID: 9783695
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
    Torti C, Lapadula G, Barreiro P, Soriano V, Mandalia S, De Silvestri A, Suter F, Maggiolo F, Antinori A, Antonucci F, Maserati R, El Hamad I, Pierotti P, Sighinolfi L, Migliorino G, Ladisa N, Carosi G, Italian MASTER Cohort.
    J Antimicrob Chemother; 2007 Jun 01; 59(6):1141-7. PubMed ID: 17434879
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
    Souza IE, Zhang W, Diaz RS, Chaloner K, Klinzman D, Stapleton JT.
    HIV Med; 2006 Jan 01; 7(1):25-31. PubMed ID: 16313289
    [Abstract] [Full Text] [Related]

  • 15. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
    Martinez V, Diemert MC, Braibant M, Potard V, Charuel JL, Barin F, Costagliola D, Caumes E, Clauvel JP, Autran B, Musset L, ALT ANRS CO15 Study Group.
    Clin Infect Dis; 2009 Jan 01; 48(1):123-32. PubMed ID: 19035778
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R, Pogány K, Fernandez Garcia E, Jurriaans S, Brinkman K, Schuitemaker H, Miedema F, Lange JM, Prins JM.
    AIDS; 2008 Aug 20; 22(13):1583-8. PubMed ID: 18670217
    [Abstract] [Full Text] [Related]

  • 18. The decline in CD4+ T lymphocytes as a function of the duration of HIV infection, age at seroconversion, and viral load.
    Soriano V, Castilla J, Gómez-Cano M, Holguín A, Villalba N, Mas A, González-Lahoz J.
    J Infect; 1998 May 20; 36(3):307-11. PubMed ID: 9661942
    [Abstract] [Full Text] [Related]

  • 19. Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus-infected patients receiving antiretroviral therapy.
    García F, Vidal C, Plana M, Cruceta A, Gallart MT, Pumarola T, Miro JM, Gatell JM.
    Clin Infect Dis; 2000 Feb 20; 30(2):392-4. PubMed ID: 10671348
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.